Remedent Inc Revenue Growth Rates (REMI), Current and Historic Growth - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Sales Y/Y Annual
Remedent Inc   (REMI)
 

REMI's Revenue Growth by Quarter and Year

Remedent Inc 's Revenue results by quarter and year



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

REMI Revenue (in millions $) FY 2021 FY 2020 FY 2019 FY 2018
4th Quarter March -
3rd Quarter December 0.34
2nd Quarter September 0.32
1st Quarter June 0.22
FY 0.88

REMIs Annual Revenue
Remedent Inc 's Revenue in the fiscal year 2020 $ 1.06 millions
Remedent Inc 's Revenue in the fiscal year 2019 $ 1.60 millions
Remedent Inc 's Revenue in the fiscal year 2018 $ 2.70 millions
Remedent Inc 's Revenue in the fiscal year 2017 $ 2.36 millions
Remedent Inc 's Revenue in the fiscal year 2016 $ 2.77 millions




REMI Revenue third quarter 2021 Y/Y Growth Comment
Remedent Inc achieved in the third quarter 2021, above Company average Revenue growth of 29.8% year on year, to $ 0.34 millions.

Looking into third quarter 2021 results within Medical Equipment & Supplies industry 37 other companies have achieved higher Revenue growth. While Remedent Inc ' s Revenue rise of 29.8% ranks overall at the positon no. 729 in the third quarter 2021.


REMI Revenue ( Y/Y Growth %) 2021
 2020 2019 2018
4th Quarter March - -37.5 % -16.67 % -11.11 %
3rd Quarter December 29.8 % -38.1 % -44 % 27.12 %
2nd Quarter September 33.33 % -31.43 % -48.53 % 11.48 %
1st Quarter June -29.03 % -27.91 % -45.57 % 27.42 %
FY   - -33.75 % -40.74 % -

Financial Statements
Remedent Inc 's third quarter 2021 Revenue $ 0.34 millions REMI's Income Statement
Remedent Inc 's third quarter 2020 Revenue $ 0.26 millions Quarterly REMI's Income Statement


REMI Revenue (Quarter on Quarter Growth %)

 2021
 2020 2019 2018
4th Quarter March - -3.85 % -4.76 % -36 %
3rd Quarter December 5.46 % 8.33 % 20 % 10.29 %
2nd Quarter September 45.45 % -22.58 % -18.6 % -13.92 %
1st Quarter June -12 % -22.5 % -10.42 % 46.3 %
FY (Year on Year)   - -33.75 % -40.74 % -


Back to REMI Growth rate Comparisons >> Back to REMI Growth rate Comparisons >>


Revenue third quarter 2021 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #38
Healthcare Sector #175
Overall #729

Revenue Y/Y Growth Statistics
High Average Low
76.69 % -8.28 % -80.91 %
(Sep 30 2013)   (Mar 31 2014)
Revenue third quarter 2021 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #38
Healthcare Sector #175
Overall #729
Revenue Y/Y Growth Statistics
High Average Low
76.69 % -8.28 % -80.91 %
(Sep 30 2013)   (Mar 31 2014)

Revenue by Quarter for the Fiscal Years 2018, 2019, 2020, 2021

Remedent Inc 's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
256.18 % 4.97 % -100 %
(Jun 30 2014)  


REMI's III. Quarter Q/Q Revenue Comment
Remedent Inc achieved in the III. Quarter 2021 above company average sequential Revenue increase of 5.46%, to $ 0.34 millions, from $0.32 millions in the second quarter.

Within Medical Equipment & Supplies industry 86 other companies have achieved higher Revenue quarter on quarter growth. While Remedent Inc 's Revenue growth quarter on quarter, overall rank is 1690.


Revenue Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #87
Healthcare Sector #288
Overall #1690
Revenue Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #87
Healthcare Sector #288
Overall #1690
Revenue Q/Q Growth Statistics
High Average Low
256.18 % 4.97 % -100 %
(Jun 30 2014)  


REMI's III. Quarter Q/Q Revenue Comment
Remedent Inc achieved in the III. Quarter 2021 above company average sequential Revenue increase of 5.46%, to $ 0.34 millions, from $0.32 millions in the second quarter.

Within Medical Equipment & Supplies industry 86 other companies have achieved higher Revenue quarter on quarter growth. While Remedent Inc 's Revenue growth quarter on quarter, overall rank is 1690.


Remedent Inc 's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Dec 31 2020)		 12 Months Ending
(Sep 30 2020)		 12 Months Ending
(Jun 30 2020)		 12 Months Ending
(Mar 31 2020)		 12 Months Ending
(Dec 31 2019)
Cumulative Revenue 12 Months Ending $ 1.13 $ 1.05 $ 0.97 $ 1.06 $ 1.22
Y / Y Revenue Growth (TTM) -7.32 % -23.4 % -34.17 % -33.63 % -27.69 %
Year on Year Revenue Growth Overall Ranking # 3199 # 2641 # 2947 # 3172 # 749
Seqeuential Revenue Change (TTM) 7.16 % 8.2 % -8.53 % -12.61 % -11.43 %
Seq. Revenue Growth (TTM) Overall Ranking # 2662 # 593 # 2631 # 3387 # 698


Cumulative Revenue growth Comment
Remedent Inc showed decline, but improvement compare to trailing twelve month Revenue decrease in Sep 30 2020. If the fiscal year would end in Dec 31 2020, Remedent Inc 's annual Revenue fall would be -7.32% year on year to $1 millions.

In the Healthcare sector 424 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 2641 to 3199.

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 106
Healthcare Sector # 425
Overall # 3199

Revenue TTM Y/Y Growth Statistics
High Average Low
33.39 %
 -13.8 %
-40.6 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 106
Sector # 375
S&P 500 # 2662
Cumulative Revenue growth Comment
Remedent Inc showed decline, but improvement compare to trailing twelve month Revenue decrease in Sep 30 2020. If the fiscal year would end in Dec 31 2020, Remedent Inc 's annual Revenue drop would be -7.32% year on year to $1 millions.

In the Healthcare sector 424 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 2641 to 3199.


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 106
Healthcare Sector # 425
Overall # 3199

Revenue TTM Y/Y Growth Statistics
High Average Low
33.39 %
-13.8 %
-40.6 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 106
Sector # 375
S&P 500 # 2662




Other Revenue Growth
Medical Equipment & Supplies Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
REMI's Revenue Growth Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth




Companies with similar Revenue drop for the quarter ending Dec 31 2020 within Healthcare SectorY/Y Change %Revenue for the quarter ending Dec 31 2020
Labcorp Holdings Inc 52.02%$ 52.021 millions
Allied Healthcare Products inc 51.90%$ 51.900 millions
Invitae Corporation51.51%$ 51.514 millions
Aethlon Medical Inc 51.13%$ 51.133 millions
La Jolla Pharmaceutical Company51.05%$ 51.048 millions
Nuwellis Inc 49.52%$ 49.525 millions
Chembio Diagnostics Inc 49.28%$ 49.283 millions
10x Genomics Inc 49.05%$ 49.050 millions
Diversicare Healthcare Services Inc 48.40%$ 48.400 millions
Jrsis Health Care Corp48.26%$ 48.259 millions
Atrium Therapeutics Inc 48.24%$ 48.235 millions
Optinose Inc 47.52%$ 47.523 millions
Arbutus Biopharma Corp47.47%$ 47.466 millions
Guided Therapeutics Inc 47.06%$ 47.059 millions
Strongbridge Biopharma plc46.74%$ 46.736 millions
Viemed Healthcare Inc 45.48%$ 45.477 millions
Novocure Limited45.06%$ 45.064 millions
Sarepta Therapeutics Inc 44.97%$ 44.974 millions
Elanco Animal Health Incorporated44.82%$ 44.816 millions
Aclaris Therapeutics Inc 44.29%$ 44.292 millions
Astrazeneca Plc43.40%$ 43.403 millions
Organogenesis Holdings Inc 43.09%$ 43.087 millions
Bionano Genomics Inc 43.02%$ 43.019 millions
Supernus Pharmaceuticals inc 42.92%$ 42.920 millions
Sanara Medtech Inc 42.83%$ 42.827 millions
Hookipa Pharma inc 42.70%$ 42.703 millions
Decoy Therapeutics Inc 42.38%$ 42.383 millions
Therapeuticsmd Inc 41.98%$ 41.976 millions
Infinity Pharmaceuticals Inc 41.69%$ 41.694 millions
Prothena Corporation Public Limited Company40.62%$ 40.625 millions


About Remedent Inc Revenue Growth Rates (REMI), Current and Historic Growth - CSIMarket Analysis

How we calculate this

This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years). Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.

Last updated

  • Page updated:
  • Data lineage: SEC filings → XBRL parse → normalization CSIMarket.com Database → growth calculations.
  • Figures are derived from filed reports and may be restated; numbers are subject to revision.

Sources: the company’s SEC filings (XBRL/Inline XBRL) and CSIMarket.com’s normalization & QA processes.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.